Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Complementary Roles of Iron and Estrogen in Menopausal Differences in Cardiometabolic Outcomes Publisher Pubmed



Ahanchi NS1, 2, 3 ; Khatami F1, 2, 4 ; Llanaj E5, 6 ; Quezadapinedo HG7, 8, 9 ; Dizdari H1 ; Bano A1, 7 ; Glisic M1, 10 ; Eisenga MF11 ; Vidal PM3 ; Muka T12
Authors
Show Affiliations
Authors Affiliations
  1. 1. Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
  2. 2. Graduate School for Health Sciences, University of Bern, Bern, Switzerland
  3. 3. Department of Internal Medicine, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
  4. 4. Community Medicine Department, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
  6. 6. German Center for Diabetes Research (DZD), Munchen-Neuherberg, Germany
  7. 7. Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland
  8. 8. The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
  9. 9. Department of Pediatrics Erasmus MC-Sophia Children's Hospital University, Rotterdam, Netherlands
  10. 10. Swiss Paraplegic Research, Nottwil, Switzerland
  11. 11. Division of Nephrology, Department of Internal Medicine, University of Groningen, Groningen, Netherlands
  12. 12. Epistudia, Bern, Switzerland

Source: Clinical Nutrition Published:2024


Abstract

Biological hormonal changes are frequently cited as an explanatory factor of sex and menopause differences in cardiometabolic diseases (CMD) and its associated risk factors. However, iron metabolism which varies between sexes and among women of different reproductive stages could also play a role. Recent evidence suggest that iron may contribute to CMD risk by modulating oxidative stress pathways and inflammatory responses, offering insights into the mechanistic interplay between iron and CMD development. In the current review, we provide a critical appraisal of the existing evidence on sex and menopausal differences in CMD, discuss the pitfall of current estrogen hypothesis as sole explanation, and the emerging role of iron in CMD as complementary pathway. Prior to menopause, body iron stores are lower in females as compared to males, but the increase during and after menopause, is tandem with an increased CMD risk. Importantly, basic science experiments show that an increased iron status is related to the development of type 2 diabetes (T2D), and different cardiovascular diseases (CVD). While epidemiological studies have consistently reported associations between heme iron intake and some iron biomarkers such as ferritin and transferrin saturation with the risk of T2D, the evidence regarding their connection to CVD remains controversial. We delve into the factors contributing to this inconsistency, and the limitation of relying on observational evidence, as it does not necessarily imply causation. In conclusion, we provide recommendations for future studies on evaluating the potential role of iron in elucidating the sex and menopausal differences observed in CMD. © 2024 The Author(s)
Experts (# of related papers)